Tg Therapeutics (TGTX) Income from Non-Controlling Interests (2010 - 2012)

Tg Therapeutics' Income from Non-Controlling Interests history runs 3 years deep, the most recent figure standing at -$8.1 million for Q3 2012.

• On a quarterly basis, Income from Non-Controlling Interests fell 534199.07% year-over-year to -$8.1 million in Q3 2012; TTM through Sep 2013 was -$8.1 million, a 65.0% increase from a year earlier, with the FY2012 full-year figure at -$8.1 million, down 22430.3% from the prior year.
• Income from Non-Controlling Interests declined to -$8.1 million in Q3 2012 per TGTX's latest filing, from -$7.8 million in the prior quarter.
• Across five years, Income from Non-Controlling Interests topped out at $2419.0 in Q4 2010 and bottomed at -$8.1 million in Q3 2012.
• The 3-year median for Income from Non-Controlling Interests is -$19592.0 (2011), against an average of -$3.3 million.
• Across the five-year window, Income from Non-Controlling Interests slumped 909.92% in 2011 and slumped 534199.07% in 2012, its largest moves.
• Year by year, Income from Non-Controlling Interests stood at $2419.0 in 2010, then slumped by 909.92% to -$19592.0 in 2011, then slumped by 41079.64% to -$8.1 million in 2012.
• Per Business Quant, the three latest TGTX Income from Non-Controlling Interests figures stand at -$8.1 million (Q3 2012), -$7.8 million (Q2 2012), and -$7.1 million (Q1 2012).